Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression

Psychiatry and Clinical Neurosciences

Volumn 68, Issue 5, 2014, Pages 344-352

  Wang, Xiaoquan ^a   Wang, Zusen ^a   Wu, Yanfeng ^b   Yuan, Yonggui ^c   Hou, Zhenghua ^a   Hou, Gang ^d  

^a The 4th People s Hospital of Wuhu City   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

catechol O methyltransferase; cognitive function; late onset; major depressive disorder; methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2) GENE; AGED; ARTICLE; CATECHOL METHYLTRANSFERASE GENE; COGNITION; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE; GENOTYPE; HUMAN; LATE ONSET DEPRESSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROPSYCHOLOGICAL TEST; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ALLELE; CASE CONTROL STUDY; DEPRESSIVE DISORDER, MAJOR; EPISTASIS; GENETICS; ONSET AGE; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

AGE OF ONSET; AGED; ALLELES; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; COGNITION; DEPRESSIVE DISORDER, MAJOR; EPISTASIS, GENETIC; FEMALE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899421079     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12133     Document Type: Article

References (43)

1. Crocco EA, Castro K, Loewenstein DA,. How late-life depression affects cognition: Neural mechanisms. Curr. Psychiatry Rep. 2010; 12: 34-38.
2. Lyness JM, Caine ED, King DA, Conwell Y, Duberstein PR, Cox C,. Depressive disorders and symptoms in older primary care patients: One-year outcomes. Am. J. Geriatr. Psychiatry 2002; 10: 275-282.
3. Brodaty H, Luscombe G, Parker G, et al. Early and late onset depression in old age: Different aetiologies, same phenomenology. J. Affect. Disord. 2001; 66: 225-236.
4. Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L,. Cognitive impairment in major depression. Eur. J. Pharmacol. 2010; 26: 83-86.
5. Kohn R, Epstein-Lubow G,. Course and outcomes of depression in the elderly. Curr. Psychiatry Rep. 2006; 8: 34-40.
6. Lachman HM, Papolos DF, Saito T Yu YM, Szumlanski CL, Weinshilboum RM,. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
7. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D,. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 2002; 159: 652-654.
8. Barnett JH, Jones PB, Robbins TW, Müller U,. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol. Psychiatry 2007; 12: 502-509.
9. Goldberg TE, Egan MF, Gscheidle T, et al. Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry 2003; 60: 889-896.
10. de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R, Nilsson LG,. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav. Genet. 2004; 34: 533-539.
11. Strauss J, Barr CL, George CJ, et al. BDNF and COMT polymorphisms: Relation to memory phenotypes in young adults with childhood-onset mood disorder. Neuromolecular Med. 2004; 5: 181-192.
12. Potter GG, Taylor WD, McQuoid DR, Steffens DC, Welsh-Bohmer KA, Krishnan KR,. The COMT Val158Met polymorphism and cognition in depressed and nondepressed older adults. Int. J. Geriatr. Psychiatry 2009; 24: 1127-1133.
13. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE,. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci. 2001; 22: 195-201.
14. Gilbody S, Lewis S, Lightfoot T,. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am. J. Epidemiol. 2007; 165: 1-13.
15. Wu YL, Ding XX, Sun YH, et al. Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013; 46C: 78-85.
16. Elkins JS, Johnston SC, Ziv E, Kado D, Cauley JA, Yaffe K,. Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in older women. Am. J. Epidemiol. 2007; 166: 672-678.
17. Roffman JL, Weiss AP, Deckersbach T, et al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008; 147B: 990-995.
18. First MS, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I: Clinician Version), 4th edn. American Psychiatric Press, Washington, DC, 1997.
19. Zhang MY,. Handbook of Rating Scales in Psychiatry. Hunan Science Technology Press, Changsha, DC, 1998 (in Chinese).
20. Katzman R, Zhang MY, Ouang-Ya-Qu, et al. A Chinese version of the Mini-Mental State Examination: impact of illiteracy in a Shanghai dementia survey. J. Clin. Epidemiol. 1988; 41: 971-978.
21. Guo Q, Lu C, Hong Z,. Auditory Verbal Memory Test in Chinese elderly. Chin. Ment. Health J. 2001; 15: 13-15 (in Chinese).
22. Lewandowski LJ,. The Symbol Digit Modalities Test: A screening instrument for brain-damaged children. Percept. Mot. Skills 1984; 59: 615-618.
23. Zhang MY, Fan B, Cai GJ, et al. Fuld Object Memory evaluation and dementia diagnosis. Chin. J. Nerv. Ment. Dis. 1992; 18: 83-86 (in Chinese).
24. Gong Y,. Manual for the Wechsler Intelligence Scale for Adult-Chinese Revised. Hunan Map Press, Changsha, DC, 1992 (in Chinese).
25. Lu J, Guo Q, Hong Z, Shi W, Lv C,. Trail making test used by Chinese elderly patients with mild cognitive impairment and mild Alzheimer's dementia. Chin. J. Clin. Psychol. 2006; 13: 118-120 (in Chinese).
26. Shi YY, He L,. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005; 15: 97-98.
27. Kendler KS, Gatz M, Gardner CO, Pedersen NL,. A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 2006; 163: 109-114.
28. Goltser-Dubner T, Galili-Weisstub E, Segman RH,. Genetics of unipolar major depressive disorder. Isr. J. Psychiatry Relat. Sci. 2010; 47: 72-82.
29. Lohoff FW,. Overview of the genetics of major depressive disorder. Curr. Psychiatry Rep. 2010; 12: 539-546.
30. Ohara K, Nagai M, Suzuki Y, Ohara K,. Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression. Neuroreport 1998; 9: 1305-1308.
31. Hong ED, Taylor WD, McQuoid DR, et al. Influence of the MTHFR C677T polymorphism on magnetic resonance imaging hyperintensity volume and cognition in geriatric depression. Am. J. Geriatr. Psychiatry 2009; 17: 847-855.
32. Wang X, Hou Z, Yuan Y, et al. Association study between plasma GDNF and cognitive function in late-onset depression. J. Affect. Disord. 2011; 132: 418-421.
33. Elderkin-Thompson V, Mintz J, Haroon E, Lavretsky H, Kumar A,. Executive dysfunction and memory in older patients with major and minor depression. Arch. Clin. Neuropsychol. 2007; 22: 261-270.
34. Herrmann LL, Goodwin GM, Ebmeier KP,. The cognitive neuropsychology of depression in the elderly. Psychol. Med. 2007; 37: 1693-1702.
35. Rose EJ, Ebmeier KP,. Pattern of impaired working memory during major depression. J. Affect. Disord. 2006; 90: 149-161.
36. Belanoff JK, Kalehzan M, Sund B, Fleming Ficek SK, Schatzberg AF,. Cortisol activity and cognitive changes in psychotic major depression. Am. J. Psychiatry 2001; 158: 1612-1616.
37. Lee RS, Hermens DS, Porter MA, Redoblado-Hodge MA,. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J. Affect. Disord. 2012; 140: 113-124.
38. Savitz J, Solms M, Ramesar R,. The molecular genetics of cognition: Dopamine, COMT and BDNF. Genes Brain Behav. 2006; 5: 311-328.
39. Forn C, Belloch V, Bustamante JC, et al. A symbol digit modalities test version suitable for functional MRI studies. Neurosci. Lett. 2009; 456: 11-14.
40. Roffman JL, Gollub RL, Calhoun VD, et al. MTHFR 677C - > T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val - > Met. Proc. Natl Acad. Sci. U.S.A. 2008; 105: 17573-17578.
41. Pan CC, McQuoid DR, Taylor WD, Payne ME, Ashley-Koch A, Steffens DC,. Association analysis of the COMT/MTHFR genes and geriatric depression: An MRI study of the putamen. Int. J. Geriatr. Psychiatry 2009; 24: 847-855.
42. Tunbridge EM, Harrison PJ, Warden DR, Johnston C, Refsum H, Smith AD,. Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008; 147B: 996-999.
43. Caldú X, Vendrell P, Bartrés-Faz D, et al. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 2007; 37: 1437-1444.